Originally published by our sister publication Pain Medicine News
Patients with severe cancer pain who are on intrathecal opioids and/or local anesthetics can benefit from the addition of intrathecal clonidine, according to the results of a new investigation.
The study found that adding the alpha-2 agonist clonidine as second- or third-line therapy was not only safe and well tolerated across a wide dosing range, but also seemed to play a beneficial role in reducing side effects from increasing